【产品手册】美敦力Medtronic_产品宣传册Brochure_Minimed_640g_市场营销.docx

【产品手册】美敦力Medtronic_产品宣传册Brochure_Minimed_640g_市场营销.docx

  1. 1、本文档共8页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
THE ONLY SYSTEM^ CLINICALLY PROVEN TO REDUCE HYPOGLYCAEMIA MINIMED? 640G SYSTEM^ WITH SMARTGUARD? TECHNOLOGY HYPOGLYCAEMIA IS CHALLENGING FOR GLYCAEMIC CONTROL1 AND QUALITY OF LIFE2 Achieving good glucose control without the risk or fear of going low is a challenging balancing act for you and your patients. ON AVERAGE A PATIENT EXPERIENCES SYMPTOMATIC HYPOS PER WEEK.1 26%OF SEVERE HYPOGLYCAEMIC EVENTS LEAD TO 26% SEIZURES COMA.4  OF TYPE 1 74%PATIENTS REPORT ALTERING INSULIN DOSES OUT OF FEAR OF HYPOGLYCAEMIA.3 74% POOR GLYCAEMIC CONTROL PROVIDES RISK FOR BOTH DEVELOPMENT AND PROGRESSION OF DIABETES COMPLICATIONS.5 Patients with severe hypoglycaemia have a greater fear of hypos, more diabetes-related distress and poorer general emotional wellbeing.3 3OF EM8ERGEN%CY MEDICAL SERVICE CALL OUTS FOR HYPOGLYCAEMIA RESULT IN HOSPITALISATION.6 “Hypoglycaemia is the biggest barrier to good glycaemic control in patients with type 1 diabetes. It causes fear and worry for patients and is costly to our healthcare budgets.” Dr Conget MINIMED 640G SYSTEM^ WITH SMARTGUARD PROVIDES ADVANCED PROTECTION AGAINST HYPOGLYCAEMIA7 OF OF SMARTGUARD EVENTS DID NOT HIT THE LOW GLUCOSE LIMIT.8 Based upon SmartGuard real life data from 4,818 patients* SmartGuard, our exclusive closed loop technology, provides protection against hypoglycaemia.8 It can: HELP PREVENT SEVERE HYPOGLYCAEMIC EPISODES Automatically stops insulin when sensor glucose is predicted to approach a pre-set low limit. HELP AVOID HYPERGLYCAEMIC REBOUND Resumes insulin delivery when levels recover. HELP PROVIDE BETTER PROTECTION AGAINST LOWS Allows your patients to set multiple low limits throughout the day and night. TRUST SMARTGUARD TO DO THE WORK NO INCREASE IN HYPERGLYCAEMIA SmartGuard technology provides advanced protection from hypoglycaemia without significant increase in hyperglycaemia.1 12.0SmartGuard feature:10.08.06.0 12.0 SmartGuard feature: 10.0 8.0 6.0 4.0 2.0 0 -2 -1 0 1 2 3 4 5 6 Time from the Suspend event (h

您可能关注的文档

文档评论(0)

行业研究报告 + 关注
实名认证
服务提供商

市场分析:提供详细的市场规模、市场趋势、市场需求以及竞争格局的分析,帮助客户了解行业的现状和发展前景。 竞争对手研究:深入分析主要竞争对手的市场份额、业务模式、优势劣势等,提供差异化竞争策略建议。 行业动态:跟踪行业最新的政策法规、技术创新和市场动向,帮助客户及时掌握行业变化。 客户需求分析:研究目标客户的偏好、消费习惯和需求变化,为产品定位和市场营销提供支持。 投融资分析:分析行业内的投融资活动和资本流向,帮助客户评估投资机会和风险。

版权声明书
用户编号:7144145123000015

1亿VIP精品文档

相关文档